Health advisers overwhelmingly indicate Brainstorm's stem cell-based approach has not been shown effective for patients with the fatal muscle-wasting disease

Merck's molnupiravir has been used in Israel and other countries since late 2021 to treat symptomatic patients with risk factors that could lead to hospitalization or death

Company aims for FDA approval so that its novel cell therapy for radiation sickness can be eligible for US Strategic National Stockpile

Leqembi is first medicine convincingly shown to modestly slow cognitive decline, but some experts say effect too subtle, note dangers

Ben-Gurion University researchers develop innovative biosensor, team up with Israeli biotech company OncoHost in bid for FDA approval

GrayMatters Health says world's first non-invasive apparatus for stress disorder will teach patients how to regulate activity in the part of the brain that controls emotion

Acting chair of FDA vaccine advisory committee hopes Israel’s stellar performance in COVID research will persist on other topics and have ‘continuing effect’ on US health policy

Entrepreneur says Neuralink in the process of asking authorities to soon allow them to test the device linking brains to computers, but timeline is far from certain

US faith-based group leads 'near-shoring' Abraham Accords push to open regional FDA office with bipartisan support in Washington, but health agencies yet to give public backing

Combo shots modified to better protect against Omicron strains while still targeting earlier versions of the virus